Wirth K, Schoepf E, Mertelsmann R, Lindemann A
Department of Haematology/Oncology, Albert-Ludwigs-Universität Freiburg, Germany.
Br J Dermatol. 1998 Mar;138(3):533-5. doi: 10.1046/j.1365-2133.1998.02141.x.
Thrombocytosis is the cause of various complications in myeloproliferative disorders. We present the case of a 54-year-old woman with chronic myelogenous leukaemia who developed large ulcers on both lower legs that were refractory to standard treatment. As concomitant thrombocytosis persisted despite treatment with hydroxyurea, the new megakaryocyte inhibitor anagrelide (Agrelin) was administered and led to normalization of the platelet count within 11 days. The leg ulcers started to heal after 2 weeks and disappeared over a period of 5 months. Our findings argue for a pathogenic role of platelets in the development of leg ulcers in patients with thrombocytosis due to a myeloproliferative disorder.
血小板增多症是骨髓增殖性疾病中各种并发症的病因。我们报告一例54岁慢性粒细胞白血病女性患者,其双下肢出现大溃疡,对标准治疗无效。尽管使用羟基脲治疗,但伴随的血小板增多症持续存在,于是给予新型巨核细胞抑制剂阿那格雷(Agrelin),血小板计数在11天内恢复正常。2周后腿部溃疡开始愈合,并在5个月内消失。我们的研究结果表明,在骨髓增殖性疾病导致血小板增多症的患者中,血小板在腿部溃疡的发生中起致病作用。